目的：研究和借鉴美国食品药品监督管理局(FDA)对“新兴制药技术”的监管理念，以促进我国制药业主动迎接新技术挑战，实现创新发展。方法：梳理和分析FDA对“新兴制药技术”的认定、 分类、监管理念、应用考量与实践等。结果与结论：新兴制药技术也将是我国制药业发展的一次重要机遇，监管部门应深入研究并明确监管政策，推动其产业应用。
Abstract
Objective: To study and use the experience of the regulatory philosophy of emerging pharmaceutical technologies issued by US Food and Drug Administration so as to facilitate China's pharmaceutical industry in grasping the important opportunity of the application of emerging pharmaceutical technologies. Methods: The definition, classification, regulation concepts, application considerations and practice of emerging pharmaceutical technologies by FDA were reviewed and analyzed. Results and Conclusion: The Emerging Pharmaceutical Technology is also an important opportunity for the development of China's pharmaceutical industry. The regulatory department should make a thorough study, clarify the regulatory policy and promote its industrial application.
关键词
药品；制药；新技术；美国；监管
{{custom_keyword}} /
Key words
drugs； pharmaceutical industry； emerging technologies； the United States； regulation
{{custom_keyword}} /
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] FDA.Advancement of Emerging Technology Applications for Pharmaceutical Innovation and Modernization Guidance for Industry[EB/OL].(2017-09-01)[2020-03-31].https://www.fda.gov/downloads/Drugs/GuidanceCompliance RegulatoryInformation/Guidances/UCM478821.pdf.
[2] FDA.Emerging Technology Program[EB/OL].(2019-10-01)[2020-03-31].https://www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDER/ucm523228.htm.
[3] FDA.Quality Considerations for Continuous Manufacturing Guidance for Industry Draft[EB/OL].(2019-02-01)[2020-03-31].https://www.fda.gov/media/121314/download.
[4] FDA.FDA Fiscal Year 2021 Justification of Estimates for Appropriations Committees[EB/OL].(2020-02-20)[2020-03-31].https://www.fda.gov/media/135078/download.
[5] FDA.FDA Budget Matters:Investing in Advanced Domestic Manufacturing(Posted on July 13,2018 by FDA Voice)[EB/OL].(2018-07-26)[2020-03-31].https://www.fda.gov/news-events/fda-voices-perspectives-fda-leadership-and-experts/fda-budget-matters-investing-advanced-domestic-manufacturing.
[6] FDA.Office of Pharmaceutical Quality 2019 Annual Report [EB/OL].(2020-02-10)[2020-03-31].https://www.fda.gov/media/135046/download.
[7] Adam C Fishera,Sau L Leea,Daniel P Harrisa,et al.Advancing Pharmaceutical Quality:An Overview of Science and Research in the U.S.FDA's Office of Pharmaceutical Quality[J].International Journal of Pharmaceutics,2016,515(1-2):390-402.
[8] Thomas F O'Connor,Lawrence X Yu,Sau L Lee.Emerging Technology:A Key Enabler for Modernizing Pharmaceutical Manufacturing and Advancing Product Quality[J].International Journal of Pharmaceutics,2016,509(1-2):492-498.
[9] Rowe CW,Katstra WE,Palazzolo RD,et al.Multimechanism Oral Dosage Forms Fabricated by Three Dimensional Printing? [J].J Controlled Release,2000,66(1):11-17.
[10] FDA.Statement by FDA Commissioner Scott Gottlieb on FDA Ushering in New Era of 3D Printing of Medical Products,Provides Guidance to Manufacturers of Medical Devices[EB/OL].(2017-12-04)[2020-03-31].https://www.fda.gov/news-events/press-announcements/statement-fda-commissioner-scott-gottlieb-md-fda-ushering-new-era-3d-printing-medical-products.
[11] FDA.Modernizing the Way Drugs Are Made:A Transition to Continuous Manufacturing[EB/OL].(2017-05-17)[2020-03-31].https://www.fda.gov/drugs/news-events-human-drugs/modernizing-way-drugs-are-made-transition-continuous-manufacturing.
[12] FDA.Drug Shortages:Root Causes and Potential Solutions[EB/OL].(2020-03-11)[2020-03-31].https://www.fda.gov/drugs/drug-shortages/report-drug-shortages-root-causes-and-potential-solutions.
{{custom_fnGroup.title_cn}}
脚注
{{custom_fn.content}}
基金
国家药典委员会课题“药品质量风险及药品生命周期管理指导原则建立研究”(编号 2008Y001)
{{custom_fund}}
